Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation.

Cao D, Chen D, Xia JN, Wang WY, Zhu GY, Chen LW, Zhang C, Tan B, Li H, Li YW
Biomed Pharmacother. 2022 Nov;155:113705. doi: 10.1016/j.biopha.2022.113705. Epub 2022 Oct 7. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.